Sleep Hygiene and GLP-1 Medications: A Connection Worth Noting While lifestyle factors such as stress, diet, and activity levels are often at the forefront of sleep conversations, certain medications can also play a role in influencing sleep patterns
As featured in Wegovy is the first-ever semaglutide FDA-approved specifically for chronic weight management the highest approved dose for weight loss, backed by the STEP clinical trials
Sanofi Positioning: Sanofi is a minor player in the GLP-1 market, offering SOLIQUA , a combination therapy that merges insulin glargine with lixisenatide, a GLP-1 receptor agonist
Could sodium chloride be an environmental trigger for immune-mediated diseases
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
GLP-1 receptors are expressed on up to 70% cerebral arterioles [18] and endothelial cells, and experimental models demonstrate that GLP-1 signaling promotes arteriolar vasodilation, improved endothelial nitric oxide signaling, and angiogenic pathways such as VEGF upregulation, all of which enhance nutrient and oxygen delivery to metabolically active brain regions [13,14]
